Latest news

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research

Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…

Raidium joins Debiopharm Innovation Fund Portfolio

Debiopharm mutualise son infrastructure de bornes de recharges pour les taxis électriques ou hybrides de Lausanne

MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead’s…

Lancement de la 10e édition du Challenge Qualité de Vie du Patient

Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways

Debiopharm Innovation Fund welcomes Hope AI to their portfolio

Swiss-based non-profit GARDP supports the development of Debiopharm’s new potential treatment for gonorrhoea